Each year, we offers a wide range of funded PhD projects, including clinical, non-clinical and MB-PhD opportunities. Explore our current opportunities below.
Sugarcoating a bitter pill: Identifying how mucinous tumours use glycobiology for chemoresistance
The VIGILANCE study: developing imaging and circulating biomarkers towards personalised radiotherapy in locally advanced lung cancer
Defining 3D characteristics of high-risk pancreatic precancer lesions for interception
Beyond BRCA1/2: dissecting drivers of chromosome instability in high-grade serous ovarian cancer
Frailty assessment using imaging-derived body composition analysis to inform personalised anal cancer treatment – reverse and forward translation within the PLATO trial platforms
Multimodal analysis of the locoregional immune response to improve management and outcomes in patients with oesophagogastric cancer
Is the cancer-associated microbiome a key determinant of the immune response to bowel cancer or are immunogenetic lesions more important?
Investigation of signalling from the microenvironment in metastasis of invasive lobular breast cancer
Gene regulatory networks driving metastatic progression in oesophageal adenocarcinoma
Multiomic investigation of the molecular mechanisms during differential treatment response in breast cancers
Smaller, Better, Faster, Stronger: real-time colorectal cancer management using nanopore sequencing
MYST Histone Acetyl Transferases as Therapeutic Targets in Acute Myeloid Leukaemia